Brazil
Research Article
Choosing to Treat Membranous Nephropathy: A 30-year Experience
Author(s): Mary Carla Estevez Diz and Gianna Mastroianni KirsztajnMary Carla Estevez Diz and Gianna Mastroianni Kirsztajn
Background: Membranous nephropathy (MN) is one of the most frequent causes of nephrotic syndrome in adults. The clinical course is variable, and its treatment is still a matter of controversies. The aim of this study was to establish when immunosuppressive (IMS) therapy should be indicated in our population with MN.
Methods: We evaluated retrospectively clinical and laboratorial data from 71 patients with primary MN, followed in the Glomerulopathy Section (UNIFESP), from 1976 to 2006.
Results: Ten of the 71 patients have not received any specific IMS treatment, while the remainders were submitted to several specific therapies. The final mean creatinine in the non-treated (2.0 ± 1.83 mg/dL) was higher than that of the treated group (1.66 ± 1.54 mg/dL) and there was a strong and significant difference betwe.. Read More»
DOI:
10.4172/2161-0959.S5-001
Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report